GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vaxcyte Inc (FRA:5VA) » Definitions » Float Percentage Of Total Shares Outstanding

Vaxcyte (FRA:5VA) Float Percentage Of Total Shares Outstanding : 88.10% (As of Dec. 15, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Vaxcyte Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Vaxcyte's float shares is 109.80 Mil. Vaxcyte's total shares outstanding is 124.64 Mil. Vaxcyte's float percentage of total shares outstanding is 88.10%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Vaxcyte's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Vaxcyte's Institutional Ownership is 89.47%.

Vaxcyte Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Vaxcyte's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=109.80/124.64
=88.10%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vaxcyte Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vaxcyte Inc (FRA:5VA) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
HALO IMVT BBIO CERE ASND MRTX ABCZF ACAD IMGN INSM OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
PCVX:USA
Address
825 Industrial Road, Suite 300, San Carlos, CA, USA, 94070
Website
https://www.vaxcyte.com
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.

Vaxcyte Headlines

No Headlines